Content area

|
|

Cannabinoider til behandling af neuropatiske smerter

Forfatter(e)
Lasse Østergaard Andersen, Thomas Peter Enggaard & Jette Højsted Tværfagligt Smertecenter, Rigshospitalet Ugeskr Læger 2018;180:V08170602
Reference: 
Ugeskr Læger 2018;180:V08170602
Blad nummer: 
Sidetal: 
2-7
Cannabinoids for neuropathic pain management
Pharmacological treatment of neuropathic pain is associated with side effects and limited efficacy. Recently, the interest in cannabis-based medicine has led to legalisation of medical cannabis in some countries. The aim of this review is to evaluate the evidence of cannabinoids in neuropathic pain. Seventeen trials were identified; eight reported an analgesic efficacy of cannabis-based medicine, and the remaining trials showed no analgesic efficacy. Conclusions were limited by design of studies and short duration of treatment. Overall, the reduction in pain was minimal.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Per Kjærsgaard | 19/01
1 Kommentar
af Peter Søndergaard | 18/01
3 kommentarer
af Mads Henrik Koch Hansen | 16/01
2 kommentarer
af Lars Guttorm | 14/01
5 kommentarer
af Morten Ellemose Gulev | 14/01
4 kommentarer
af Henning Damgaard Laugesen | 14/01
1 Kommentar
af Jette E. Hansen Kristiansen | 14/01
1 Kommentar
af Eva Pernille Due | 13/01
6 kommentarer